LG
BMY icon

LaFleur & Godfrey’s Bristol-Myers Squibb BMY Stock Holding History

LaFleur & Godfrey’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11M Sell
36,644
-177
-0.5% -$10.2K 0.25% 65
2026
Q1 		$2.23M Buy
36,821
+1,636
+5% +$95.4K 0.28% 62
2025
Q4 		$1.9M Sell
35,185
-2,251
-6% -$108K 0.23% 66
2025
Q3 		$1.69M Sell
37,436
-4,007
-10% -$187K 0.2% 71
2025
Q2 		$1.92M Sell
41,443
-2,128
-5% -$104K 0.24% 66
2025
Q1 		$2.66M Buy
43,571
+20
+0% +$1.17K 0.36% 64
2024
Q4 		$2.46M Buy
43,551
+1,487
+4% +$83.1K 0.34% 62
2024
Q3 		$2.18M Buy
42,064
+3,222
+8% +$151K 0.3% 66
2024
Q2 		$1.61M Sell
38,842
-12,648
-25% -$566K 0.24% 69
2024
Q1 		$2.79M Buy
51,490
+9,436
+22% +$481K 0.41% 63
2023
Q4 		$2.16M Sell
42,054
-4,619
-10% -$242K 0.32% 66
2023
Q3 		$2.71M Sell
46,673
-63,855
-58% -$3.91M 0.43% 57
2023
Q2 		$7.07M Buy
110,528
+37
+0% +$2.48K 1.06% 32
2023
Q1 		$7.66M Sell
110,491
-89
-0.1% -$6.28K 1.26% 27
2022
Q4 		$7.96M Sell
110,580
-2,544
-2% -$192K 1.33% 26
2022
Q3 		$8.04M Sell
113,124
-9,114
-7% -$661K 1.43% 25
2022
Q2 		$9.41M Sell
122,238
-59,980
-33% -$4.57M 1.49% 23
2022
Q1 		$13.3M Sell
182,218
-580
-0.3% -$38.9K 1.79% 16
2021
Q4 		$11.4M Buy
182,798
+19,758
+12% +$1.16M 1.46% 23
2021
Q3 		$9.65M Buy
163,040
+14,680
+10% +$967K 1.33% 29
2021
Q2 		$9.91M Buy
148,360
+34,098
+30% +$2.22M 1.42% 25
2021
Q1 		$7.21M Buy
114,262
+18,881
+20% +$1.17M 1.4% 30
2020
Q4 		$5.92M Buy
95,381
+76,875
+415% +$4.73M 1.21% 33
2020
Q3 		$1.12M Buy
+18,506
New +$1.11M 0.25% 60
2016
Q1 		– Sell
-3,007
Closed -$207K – 72
2015
Q4 		$207K Buy
+3,007
New +$199K 0.06% 72

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

LaFleur & Godfrey's BMY Position: Q2 2026 in Review

LaFleur & Godfrey reduced its Bristol-Myers Squibb (BMY) stake by 0.48% in Q2 2026, selling an estimated $10.2K and leaving 36,644 shares worth $2.11M. The position accounts for 0.25% of the portfolio, ranked #65.

LaFleur & Godfrey first reported a position in BMY in Q4 2015 and has held it in 25 quarters since. The position peaked at $13.3M in Q1 2022. 744 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • LaFleur & Godfrey held 36,644 shares of Bristol-Myers Squibb worth $2.11M as of Q2 2026.
  • LaFleur & Godfrey sold 177 Bristol-Myers Squibb shares in Q2 2026, an estimated $10.2K.
  • Bristol-Myers Squibb made up 0.25% of LaFleur & Godfrey's portfolio in Q2 2026, its #65 holding.
  • LaFleur & Godfrey first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 25 quarters since.
  • LaFleur & Godfrey's Bristol-Myers Squibb position peaked at $13.3M in Q1 2022.
  • 744 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on LaFleur & Godfrey's 13F filing for Q2 2026, filed 15 Jul 2026.